Clinical Trials
15 trialsNCT05236764 2025-10-30
HAPLOTAB
Baylor College of Medicine
Phase NA Active not recruiting
NCT03266653 2025-08-08
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
New York Medical College
Phase 2 Recruiting
NCT06999954 2025-05-31
SDS-GPS
Shwachman-Diamond Syndrome Alliance Inc
Recruiting
NCT03475212 2025-05-11
ACES
Pediatric Transplantation & Cellular Therapy Consortium
Phase 1/2 Active not recruiting
NCT02061800 2024-06-04
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University
Phase 1/2 Active not recruiting
NCT02065869 2023-09-29
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
Bellicum Pharmaceuticals
Phase 1/2 Terminated
NCT03733249 2023-09-26
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Bellicum Pharmaceuticals
Phase 1/2 Terminated
NCT02822495 2023-06-15
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
Atara Biotherapeutics
No longer available
NCT03301168 2022-07-12
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Bellicum Pharmaceuticals
Phase 1/2 Active not recruiting
NCT02496676 2022-03-02
Magnesium Supplementation in People With XMEN Syndrome
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT04354818 2021-09-01
CORIA
Kirby Institute
Unknown
NCT03836690 2019-10-25
ToTem
University College, London
Phase 1 Unknown
NCT03668288 2019-04-04
Tolerance and Patients' Satisfaction With IGHy
CHU de Reims
Unknown
NCT03087370 2018-12-07
A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome
X4 Pharmaceuticals
Withdrawn
NCT00692926 2017-06-29
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells
Duke University
Phase 1 Completed